HAIKOU CITY, China, Oct. 28 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma”) , which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release third quarter 2009 financial results on Thursday, November 12, 2009, before the market opens.
The Company will hold a conference call at 8:00 am ET on November 12, 2009 to discuss fiscal third quarter 2009 results. Listeners may access the call by dialing 1-866-271-6130 or 1-617-213-8894 for international callers, access code: 14971758. A webcast will also be available through CPHI’s website at http://www.chinapharmaholdings.com . A replay of the call will be accessible through November 19, 2009 by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 89842045.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company’s cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
CONTACT: China Pharma Holdings, Inc., +86-898-6681-1730,
hps@chinapharmaholdings.com; or Christine Duan of ICR, Inc.,
+1-203-682-8200
Web site: http://www.chinapharmaholdings.com/
